Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

FDA 510(k)

Artificial Intelligence Renal Assessment (AIRA) Version 1

N.º K: K261677 · 2026-09-15

SolicitanteAramis Global AI Consultancies, LLC
Fecha de decisión2026-09-15
Código de productoQIH
Comité asesorRA
DecisiónSubstantially Equivalent

Resumen del dispositivo

Artificial Intelligence Renal Assessment (AIRA) Version 1 is the device name listed in this FDA 510(k) record. The listed applicant is Aramis Global AI Consultancies, LLC. It received FDA 510(k) clearance on 2026-09-15 under 510(k) number K261677. The device is classified under product code QIH. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Preguntas frecuentes

What is the Artificial Intelligence Renal Assessment (AIRA) Version 1?

Artificial Intelligence Renal Assessment (AIRA) Version 1 is a medical device that received FDA 510(k) clearance on 2026-09-15. The listed applicant is Aramis Global AI Consultancies, LLC. The 510(k) number is K261677.

When did Artificial Intelligence Renal Assessment (AIRA) Version 1 receive FDA 510(k) clearance?

Artificial Intelligence Renal Assessment (AIRA) Version 1 received FDA 510(k) clearance on 2026-09-15, under 510(k) number K261677.

Who is the listed applicant for Artificial Intelligence Renal Assessment (AIRA) Version 1?

The FDA 510(k) record lists Aramis Global AI Consultancies, LLC as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Artificial Intelligence Renal Assessment (AIRA) Version 1?

The FDA product code for Artificial Intelligence Renal Assessment (AIRA) Version 1 is QIH.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Dispositivos relacionados (Código: QIH)

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

K260055syngo.CT Brain QuantificationSiemens Medical Solutions USA, Inc.K262390BoneXpertVisianaK261368Rapid Platform (R6.7)Ischemaview, Inc.K261623EchoPAC Software Only / EchoPAC Plug-in (v211)GE Medical Systems Ultrasound and Primary Care DiagnosticsK2608794DMINVIA, LLCK261795Quicktome Software SuiteOmniscient Neurotechnology Pty, Ltd.

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.

↑